We are excited to offer MYO-T12? to Amazon.com customers," said JB Bernstein, CEO of Atlas Therapeutics. "We are very pleased to announce that MYO-T12? is available on Amazon.com," said Mitch Gould, CEO of NPI, the exclusive wholesale agent of MYO-T12?. "As the first clinically validated myostain inhibitor on the market, MYO-T12? offers a wide range of men the chance to reach their fitness goals." About Atlas Therapeutics Corporation Atlas Therapeutics Corporation owns the rights to MYO-T12?, the world's only clinically validated myostatin inhibitor